Dow Up 1.30% Nasdaq Up 0.37%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
1.01 Oct 30, 4:00PM EDT
Prev Close:1.01
Open:1.01
Bid:0.97 x 800
Ask:1.15 x 2000
1y Target Est:5.00
Beta:1.51
Next Earnings Date:N/A
Day's Range:0.95 - 1.04
52wk Range:0.73 - 2.56
Volume:103,291
Avg Vol (3m):201,792
Market Cap:28.03M
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OPXA

Comparison

Symbol% ChgMkt Cap
OPXA 0.00%28.03M
SNY119.93B
TEVA48.21B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.56
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback